Skip to main content
letter
. 2021 Jul 3;76(10):3194–3196. doi: 10.1111/all.14981

FIGURE 1.

FIGURE 1

Sweet syndrome lesions (A) First localization appeared 24 h after the vaccine injection on the back. (B) Erythematous papulosis on the left shoulder. (C) (1) Cutaneous tests: Positive IDR with SARS‐CoV‐2 Pfizer‐BioNTech mRNA vaccine diluted to 1/10e at day 5. (2) Patch test with pur SARS‐CoV‐2 Pfizer‐BioNTech mRNA vaccine in healed skin. (3) Patch test with pur SARS‐CoV‐2 Pfizer‐BioNTech mRNA vaccine in normal skin